Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
ahhhh, - that'll be Southampton / Camberley / Paris then.
Perhaps we should consider that GM advised that he was looking to perform some M&A activity in H1 2021.
This was stated shortly before purchasing IT-IS International, (October last year).
This being the case, if he wants to keep to schedule, he might be starting due diligence any time soon, for an end of June timescale, plus and minus six weeks ish.
In order that nothing gets leaked about said opportunity(s), he will have doubled down on all the different forms of communication that a company's employee's use with media, partners, customers, agents, and especially PI's.
That is a mammoth task for a company recruiting so many new faces.
How would he know which to trust etc, so I'm not sure if new staff are even aware that M&A might be a possibility.
Going through contracts with lawyers and DHSC will be a distraction for sure, but reasonably confident this may be what a fly on GM's wall might overhear ;=)
Add that lot to consideration of any offers received, and I'm not surprised GM is not saying anything, - must be like Fort Knox in Southampton.
Just a few thoughts.
Sign up from tomorrow, got another 2 weeks of fun before it's on.
Remember to sign up for the webinar tomorrow .
Who knows what they might surprise us with :)
Dr Eric dong is attending.
He’s a big un in the field ;)
For all we know negotiations are afoot with Astra or GSK , they know we have best tests in market , the staff including high level ex big pharma board executives.
GM has already told us he aims for this company to be midcap. 1 billion , £15 per share .
There is no other reason for not supporting the ever decreasing share price unless he already has a take over price in his head .
It will not be lower than the £8.15 he and his colleagues paid that’s for sure .
Soder,
I have read the contract , that which is not redacted several times. There are numerouus clauses which one can disregard because the govt and NCYT met every two weeks to discuss ?? and firm up orders, such as not meeting a target, as the contract continued. If we look at the figures that we saw invoiced to DHSC for Oct , Nov and Dec it amounts to approx 127mm , 23mm short of the guarenteed 150mm. Move to Rns 9/4 we are informed that the Promate was ordered 1st quarter 2021 , GM is quite explicit in pointing this out.
The simple conclusion is 23mm unpaid .
At some stage the NHS decided that the product they ordered Exsig and the Q32/16's were not providing as streamlined operating efficiencies as desired/ envisaged. Pause, they would have been demonstrated and approved prior to order. Ncyt develop Promate in mid November. Three is a clause that if a new product is developed then the authority has the right to swap this out at the same cost.
It is not clear to me if this is the case for a product specifically developed for them. This could be contentious but relatively easy to reach a compromise on.
There is a remedy that implementations of change must occur within two months. Promate validated Feb24th after being delivered in Nov , the govt may be trying to invoke over two months until implementation. If this is the issue then a very weak case as they were delivered what they asked for and they changed their minds and then there was a lengthy period for validation , which NCYT could not influence.
Winterplex ordered but not utilised as minimal flu due to lockdown, could they be requesting swap out of this product , if so negotiations again relatively simple.
Until we see financials it is difficult to know what the DHSC have paid thus far , indeed GM could be talking about money we should have had and the figures reported thus far will not be impacted , if that is the case ROW higher. There are so many different possible areas which could be in dispute. What to me is critical is that after phase one completed the govt continued to order , therefore showing intent to continue using purchased Q machines and that they were fit for purpose. Just my thoughts.
Losing 8 to 10n pounds may make you feel a whole lot better.
Managed to lose that myself this week.
Feel as fit as a fiddle or harp even.
I would happily take £8-10 and have this weight gone.
I wasn't suggesting it'd be approved, I just think a lowball offer that tests the reserve of shareholders is a distinct possibility now. £0.5b is hardly much of a risk to big pharma wanting more of a diagnostics presence is it?!
Harchris......no way way would they get it for £7.00...I'm still quite positive on ncyt although I think their communication has been awful, however another badly worded rns, I could start to take a different view...I'm planning on sticking around to middle of June time, and will see where we are then..
Aren't there enough conspiracy theories regards Covid itself and vaccinations without speculating about possible ones regards Novacyt ? Makes we wonder who is gambling, investing or speculating here or if they know the difference ?
Maybe a discussion for another day.
For six months I've sat quietly whilst hundreds of investors speculated about a take over, I just never considered it very likely. Now though I'm not so sure and reckon a low ball offer in the range of £7-£10 a distinct possibility.
Agree I’m being a numpty ...just lost all rational thinking. Need to switch off . Getting to us all.
Not one for conspiracy theories directly after he posts one. Quite the accusation you have made there.
Orchestrated by company to enable purchase entire company at £750m. Back January would never have been accepted such a low ball offer. Now at £3 who would vote against?
Big bonuses for BD’s if goes through & they continue at company under a parent.
Not one for conspiracy theories but with current company performance & communications, actually hoping is the case.